Valuation CSPC Pharmaceutical Group Limited

Stocks

Market Closed - Hong Kong S.E. Other stock markets 09:08:53 14/07/2026 BST			5-day change	1st Jan Change
8.110 ^HKD	-0.61%		-1.46%	-3.80%

07-07	Weight-loss drug developers line up to tap lucrative market as competition heats up	RE
07-07	CSPC Pharma Begins Phase II Trial of Mixed Hyperlipidaemia Drug	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	100,932	97,707	86,022	55,169	96,380	92,722	-	-
Change	-	-3.19%	-11.96%	-35.87%	74.7%	-3.8%	-	-
Enterprise Value (EV) ¹	89,633	86,241	72,284	46,931	86,710	81,859	79,283	76,220
Change	-	-3.79%	-16.18%	-35.07%	84.76%	-5.59%	-3.15%	-3.86%
P/E	14.7x	14.1x	13.5x	12.1x	21.8x	11.2x	13.1x	12x
PBR	3.17x	2.86x	2.39x	1.62x	2.56x	2.16x	1.98x	1.8x
PEG	-	14.13x	-1.73x	-0.5x	-9.88x	0.1x	-0.9x	1.32x
Capitalization / Revenue	2.94x	2.77x	2.52x	1.78x	3.26x	2.6x	2.63x	2.46x
EV / Revenue	2.61x	2.44x	2.12x	1.51x	2.94x	2.29x	2.25x	2.03x
EV / EBITDA	9.5x	9.43x	8.39x	6.22x	12.1x	6.5x	7.98x	7.24x
EV / EBIT	10.7x	10.8x	9.77x	7.68x	15.6x	8.89x	10.4x	9.4x
EV / FCF	23.7x	14.1x	26.2x	17.5x	19.5x	9.96x	11.3x	7.96x
FCF Yield	4.22%	7.11%	3.82%	5.71%	5.12%	10%	8.85%	12.6%
Dividend per Share ²	0.18	0.21	0.28	0.26	0.29	0.3633	0.3682	0.3827
Rate of return	2.13%	2.56%	3.86%	5.44%	3.44%	4.48%	4.54%	4.72%
EPS ²	0.5773	0.5831	0.5376	0.3946	0.3859	0.7213	0.6181	0.6742
Distribution rate	31.2%	36%	52.1%	65.9%	75.2%	50.4%	59.6%	56.8%
Net sales ¹	34,309	35,292	34,175	31,046	29,533	35,677	35,195	37,634
EBITDA ¹	9,431	9,148	8,615	7,547	7,168	12,600	9,933	10,533
EBIT ¹	8,366	7,952	7,400	6,113	5,564	9,206	7,644	8,108
Net income ¹	6,901	6,949	6,382	4,632	4,409	7,937	6,917	7,537
Net Debt ¹	-11,298	-11,467	-13,738	-8,238	-9,670	-10,863	-13,439	-16,502
Reference price ²	8.470	8.200	7.260	4.780	8.430	8.110	8.110	8.110
Nbr of stocks (in thousands)	11,916,370	11,915,520	11,848,756	11,541,665	11,433,025	11,433,025	-	-
Announcement Date	22/03/22	22/03/23	20/03/24	28/03/25	25/03/26	-	-	-

¹HKD in Million²HKD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CSPC PHARMACEUTICAL GROUP LIMITED	11.31x	2.31x	6.54x	4.45%	11.9B
ELI LILLY AND COMPANY	34.43x	12.54x	25.95x	0.57%	1,054B
JOHNSON & JOHNSON	27.51x	6.31x	17.15x	2.07%	621B
ABBVIE INC.	30.73x	7.36x	15.07x	2.77%	438B
ROCHE HOLDING AG	17.67x	4.38x	10.82x	3.03%	325B
NOVARTIS AG	21.42x	5.5x	13.31x	2.87%	281B
ASTRAZENECA PLC	21.07x	4.44x	12.4x	1.98%	262B
NOVO NORDISK A/S	14.26x	5.33x	10.96x	3.5%	219B
AMGEN INC.	23.64x	6.27x	11.07x	2.8%	195B
GILEAD SCIENCES, INC.	-47.34x	5.67x	31.3x	2.47%	163B
Average	15.47x	6.01x	15.46x	2.65%	356.81B
Weighted average by Cap.	23.60x	7.80x	18.17x	2.01%